Clearly, studies are needed to quantify benefits and harms of screening, to evaluate screening measures (e.g., eGFR equations, cystatin C, albuminuria) and target groups (e.g., older age, obesity, CVD). The gene discussed is CST4; the disease is obesity due to melanocortin 4 receptor deficiency.